Researchers at the Helmholtz Munich and the Ludwig-Maximilians-University (LMU) Munich have investigated a possible ...

Cirius Therapeutics, Inc., developing innovative therapies for patients suffering from diseases caused by insulin resistance, ...

Significant interaction seen for full psoriasis polygenic risk score with waist-to-hip ratio on psoriasis risk.

Medically reviewed by Amelia MacIntyre, DO Weight loss and fat loss are often confused as the same thing. Weight loss ...

Popular belief holds that our senses gather information only about the external world, but many of our sensory systems also monitor our internal environment, enabling the body to regulate its own ...

Arrowhead Pharmaceuticals has dosed the first participant in the Phase I/IIa AROALK7-1001 trial of ARO-ALK7, an ...

NEW YORK – Arrowhead Pharmaceuticals on Monday said it has treated the first patients with ARO-ALK7, an RNAi therapeutic that the company is developing for obesity, within a first-in-human Phase I/IIa ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) has initiated the human trial of ARO-ALK7, a novel RNA interference (RNAi) ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-ALK7, the company’s investigational RNA interference (RNAi) ...

Tissue morphogenesis requires the precise control of cell shape and cell dynamics. Cell shape is governed by cell mechanics, which explains how a set of intracellular and extracellular forces ...

However, telangiectasias are also a classic feature of certain autoimmune diseases that affect the skin and other connective tissues (also called connective tissue diseases): There are many different ...